medigraphic.com
Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular

2007, Number 2

<< Back

Rev Mex Angiol 2007; 35 (2)

Effectiveness of the FABROVEN in the functional symptomatology of venous cronic insufficiency of inferior members

Oca NJM, Alcántara TVM, Medina PRM

Language: Spanish
References: 20
Page: 70-77
PDF size: 338.35 Kb.


ABSTRACT

Objective: To determine the effectivenes in the functional symptomatology (gravity, pain legs, cramps, ardor and edema) in the patients dealt with FABROVEN (Ruscus aculeatus, hesperidina metilchalcona, ascorbic acid) with chronic venous insufficiency.
Patients and method: This study was undertaken to determine the effectiveness and tolerability of the FABROVEN (Ruscus aculeatus, hesperidina metilchalcona, ascorbic acid), in patients with chronic venous insufficiency, a period of October 2005 to August 2006), in a total of 170 patients, Treatment that received each patient was of 2 capsules per day of FABROVEN, a period of 6 months of treatment.
Sede: Policlinica "Lic. Juan Fernandez Albarran" of the Issemym, the City of Toluca, State of Mexico.
Inclusion criteria: The evaluation criteria were determined at the beginning, the 3 months and at the end of the study, and were: Functional symptomatology, (gravity and pain the legs, cramps, ardor and edema), and tolerance to the treatment. All the caught patients of first time in the external consultation with diagnose of chronic venous insufficiency, CEAP (C0, C1, C2, C3, C4, C5), of October 2005 to February 2006.
Exclusion criteria: Patients with chronic sufferings like Mellitus Diabetes, Arterial Hypertension, Neuropaty, Osteoartritis, etc.
Results: It was made the pursuit of 170 patients, by a period of three and six months with a therapeutic handling of monotherapy with FABROVEN, 113 patients of feminine sex and 57 patients of masculine, sex, with an average of age of: 35-55 years (± 5 years), with prevailed of overweight of 112 patients. At the beginning of the study the moderate pain is the symptom that frequently appear in the patients with 139 of them, followed of edema (126 patients) and cramps (125 patients), with an important diminution to three months of treatment with 65 patients who continued with moderate pain, with edema 37 patients, and 38 patients with persistence of cramps of moderate intensity, and to finish of the study it was observed diminution of pain in the legs in a 80% of patients asimptomatic, 77% of patients without edema, and in relation to the presence of cramps a 87% of patients asimptomatic.
Conclusions: The Chronic Venous Insufficiency and its complications suppose a significant deterioration of the quality of life of the patients and constitute a very limitant pathology sometimes. The present treatments, although do not allow to solve this disease, if they are effective to reduce its gravity and to improve the symptomatology. The patients dealt with FABROVEN considerably diminish the functional symptomatology of the inferior extremities mainly the presence of the pain, cramps and edema improving the quality of life of these patients. With an acceptable gastric tolerance to the treatment in the long term.


REFERENCES

  1. Feied C. Venous anatomy and physiology. American College of Phlebology [En línea] [Fecha de acceso: 19/01/2002]. Disponible en: http://www.phlebology.org/syllabus1.htm

  2. Villa i Coll MA, Fernández PJ, Fernández A MC. Insuficiencia venosa crónica de extremidades inferiores. FMC 1995; 2(1): 13-22.

  3. De Burgos MJ, García C EI, Tirado VC, Torres TM, Palomar AV. Manejo urgente de la insuficiencia venosa crónica, en atención primaria. Semergen 1998; 24(10): 839-44.

  4. Feied C. Varicose veins. eMedicine. [En línea] Sept. 1, 2001 [Fecha de acceso: 26/01/2002] Vol. 2,9. Disponible en: http://www.emedicine.com/med/topic2788.htm

  5. Nicolaides AN. Investigation of chronic venous insufficiency. A consensus statement. Circulation 2000; 102: e126-e163. [Texto completo]

  6. London N, Nash R. ABC of arterial and venous disease. Varicoseveins. BMJ 2000; 320: 1391-4. [Medline] [Texto completo]

  7. Kim J, Richards S, Kent PJ. Clinical examination of varicose veins-a validation study. Ann R Coll Surg Engl 2000; 82(3): 171-5. [Medline]

  8. Extracto de las recomendaciones para la inclusión en lista de espera quirúrgica de pacientes con várices. Capítulo de Flebología de la SEACV. [En línea] 1998 [Fecha de acceso: 19/01/2002]. Disponible en: http://www.capflebo.org/

  9. Base de datos de medicamentos, Consejo General de Colegios Oficiales de Farmacéuticos. Disponible en URL: http://www.portalfarma.com/home.nsf (consulta: abril, 2004).

  10. Precios de medias eláisticas largas de compresión fuerte: Varitex y Farmalastic. Disponible en URL: http://www.mifarmacia.es/producto.asp? Producto=../VMPT-Web/0705 (consulta: abril, 2004).

  11. Precios de apósitos estériles: Sorbsan. Disponible en URL: http://www.mifarmacia.es/producto.asp?Producto=../VMPTWeb/070604 (consulta: abril, 2004).

  12. J Herb Pharmacother. 2004; 4(2):11-8. Inhibition of COX isoforms by nutraceuticals, Seaver B, Smith JR. University of Montana, Missoula, MT, USA.

  13. Boyle P, Diehm C, Robertson C. Division of epidemiology and biostatistics. European Institute of Oncology Milan, Italy. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. Int Angiol 2003; 22(3): 250-62.

  14. Boisseau MR. Universite Victor Segalen, Bordeaux Cedex, France. Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency, Int Angiol, 2002; 21(2 Suppl. 1): 33-9.

  15. Vanscheidt W, Jost V, Wolna P. Rheintalklinik, Bad Krozingen, Germany. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency. Arzneimittelforschung 2002; 52(4): 243-50.

  16. Redman DA. American University, Washington, DC, USA. Ruscus aculeatus (butcher's broom) as a potential treatment for orthostatic hypotension, with a case report. J Altern Complement Med 2000; 6(6): 539-49.

  17. Miller VM, Rud KS, Gloviczki P. Department of Surgery, Mayo Clinic and Foundation, Rochester, MN, USA. Pharmacological assessment of adrenergic receptors in human varicose veins. Int Angiol 2000; 19(2): 176-83.

  18. Bouaziz N, Michiels C, Janssens D. Laboratoire de Biochimie et Biologie Cellulaire-Facultes Universitaires Notre-Dame de la Paix-Namur, Belgium. Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced activation of endothelial cells. Int Angiol 1999; 18(4): 306-12.

  19. Nemcova S, Gloviczki P, Rud KS. Division of Vascular Surgery, Department of Surgery, Mayo Clinic and Foundation, Rochester, Minnesota, USA. Cyclic nucleotides, and production of prostanoids in human varicose veins. J Vasc Surg 1999; 30(5): 876-83.

  20. Bouskela E, Cyrino FZ, Marcelon G. Department of Physiology and Biophysics, University of Lund, Sweden. Possible mechanisms for the inhibitory effect of Ruscus extract on increased microvascular permeability induced by histamine in hamster cheek pouch. J Cardiovasc Pharmacol 1994; 24(2): 281-5.




2020     |     www.medigraphic.com